CompoAtlas

DIABESTEOL

Food supplement declared in France, declaration No 2017-9-830

DIABESTEOL is a food supplement declared in France. Status: retiré du marché le 6 January 2022. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
LABORATOIRE CARRARE
Status
Retiré du marché le 6 January 2022
Form
Capsule
Daily dose
2 capsules
Directions for use
2 capsules par jour avant le déjeuner ou le dîner
Intended populations
Personnes de plus de 60 ans, Homme, Femme
Not recommended for (according to the manufacturer)
Enfants (moins de 12 ans), Femmes enceintes, Nourrissons (moins de 1 an), Sous antidiabétiques
Objectives stated by the manufacturer (these are not authorised claims)
Minceur / Glycémie

Declaration 283456, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Arctium lappa L.RacineExtrait sec aqueux64 mg
Trigonella foenum-graecum L.GraineExtrait sec alcoolique40 mg
Marsdenia sylvestris (Retz.) P.I.Forst.FeuilleExtrait sec aqueux40 mg
Allium sativum L.Essence (bulbe)Distillation2 mg
Eucalyptus globulus Labill.Essence (feuille)Distillation2 mg

Other active ingredients

NamePer day
Huile de poissonnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Picolinate de chromeChromepas de limite (données insuffisantes)25 µg

Additives

E322, E901, E422

Other ingredients

huile de sésame, huile de tournesol, Gélatine de poisson

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux personnes sous traitement antidiabétique. Femmes enceintes ou allaitantes : se référer à l'avis d'un médecin. Tenir hors de portée des enfants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line